In Reply to “Multiple-Biomarker Panel Estimated GFR Is Not Optimal or Cost-Effective” and “Comparing Multiple-Biomarker Panels for Estimating GFR With Estimating Equations Without a Coefficient Distinguishing Black Individuals From Persons of Other Groups”

Publication date: May 2021Source: American Journal of Kidney Diseases, Volume 77, Issue 5Author(s): Lesley A. Inker, Andrew S. Levey
Source: American Journal of Kidney Diseases - Category: Urology & Nephrology Source Type: research